Literature DB >> 16517065

Pomolic acid may overcome multidrug resistance mediated by overexpression of anti-apoptotic Bcl-2 proteins.

Janaina Fernandes1, Ricardo Weinlich, Rachel Oliveira Castilho, Gustavo Pessini Amarante-Mendes, Cerli Rocha Gattass.   

Abstract

Multidrug resistance (MDR) is multifactorial and may be mediated by overexpression of anti-apoptotic proteins. This paper investigated whether pomolic acid (PA) was able to overcome resistance mediated by overexpression of Bcl-2 or BcL-xL. The results obtained showed that overexpression of these proteins partially inhibited the PA-induced apoptosis, loss of mitochondrial membrane potential and caspase -3 and -9 activation observed in HL-60/neo. Since Bcl-2 transfected cell lines were shown to be quite resistant to a series of chemotherapeutic agents, the data presented call attention to the possible clinical significance of PA as an anti-MDR drug.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517065     DOI: 10.1016/j.canlet.2006.01.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Pomolic acid induces apoptosis in SK-OV-3 human ovarian adenocarcinoma cells through the mitochondrial-mediated intrinsic and death receptor-induced extrinsic pathways.

Authors:  Ki Hyun Yoo; Jong-Hwa Park; DO Kyung Lee; Yuan Yuan Fu; Nam In Baek; In Sik Chung
Journal:  Oncol Lett       Date:  2012-10-22       Impact factor: 2.967

2.  Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile.

Authors:  F C Vasconcelos; C R Gattass; V M Rumjanek; R C Maia
Journal:  Invest New Drugs       Date:  2007-05-23       Impact factor: 3.850

3.  Pomolic Acid Ameliorates Fibroblast Activation and Renal Interstitial Fibrosis through Inhibition of SMAD-STAT Signaling Pathways.

Authors:  Ji-Hyun Park; Kyung Mi Jang; Hyun Jin An; Jung-Yeon Kim; Mi-Gyeong Gwon; Hyemin Gu; Byoungduck Park; Kwan-Kyu Park
Journal:  Molecules       Date:  2018-09-03       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.